 Experimental immune complex-mediated glomerulonephritis nonhuman primate study model immune complex IC glomerulonephritis GN nonhuman primate subsequent studies role erythrocyte complement receptor E-CR pathogenesis IC-mediated disease Cynomolgus monkeys study E-CR levels equal normal man immunization bovine gamma globulin BGG GN induction protocol cynomolgus daily i.v administration BGG amounts sufficient antigen/antibody equivalence quantitative precipitin assay antibody present plasma volume weeks daily BGG administration cynomolgus IC-mediated GN irrespective initial E-CR level animals high E-CR cynomolgus BGG doses initial antibody levels BGG total number glomerular deposits morphometric studies total BGG dose animal initial CR/E animal tendency animals CR/E levels number glomerular deposits/BGG dose total number glomerular deposits severity GN early weeks GN induction protocol IC vivo infusion bound large amounts erythrocytes cynomolgus medium high E-CR levels onset heavy proteinuria weeks daily BGG administration IC circulation erythrocytes time E-CR levels initial values study workable model IC-mediated GN nonhuman primate induction GN CR/E ability erythrocyte IC vivo intact E-CR system role protection IC-mediated disease study hypothesis present model useful studies